News NAFDAC Approves Malaria Vaccine, Expects 100,000 Doses by John Ojewale April 18, 2023 The National Food and Drug Administration and Control (NAFDAC) has approved the R21 malaria vaccine produced by the Serum Institute, India. NAFDAC Director General Continue Reading April 18, 2023 0 comment 0 FacebookTwitterPinterestEmail